Subdivision
| • | 204. Medicine, Surgery, Pathology and Immunology | [X] |
| | 1 | Name: | Dr. Judah Folkman | | | Institution: | Harvard Medical School & Children's Hospital | | | Year Elected: | 1999 | | | Class: | 2. Biological Sciences | | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | | Residency: | Resident | | | Living? : |
Deceased
| | | Birth Date: | 1933 | | | Death Date: | January 14, 2008 | | | | |
| 2 | Name: | Dr. David G. Nathan | | | Institution: | Dana-Farber Cancer Institute & Harvard Medical School | | | Year Elected: | 1999 | | | Class: | 2. Biological Sciences | | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | | Residency: | Resident | | | Living? : |
Living
| | | Birth Date: | 1929 | | | | | | |
David Nathan is one of the most distinguished pediatric hematologists in the country. He has spent his career at Harvard University, where he has been a professor of medicine and professor of pediatrics, and in 1985 he was appointed Pediatrician-in-Chief at Childrens Hospital in Boston. In 1995 he became President of the Dana-Farber Cancer Institute. Dr. Nathan has brought to his position scientific excellence, great integrity and a warm humanity. Among other awards he has received the National Medal of Science (1990) and the Henry Stratton Medal of the American Society of Hematology (1995). He earned his M.D. from Harvard Medical School in 1955. | |
| 3 | Name: | Sir Keith Peters | | | Institution: | University of Cambridge & Christ's College | | | Year Elected: | 1999 | | | Class: | 2. Biological Sciences | | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1938 | | | | | | |
Sir Keith Peters received his M.B. B.Ch. in Wales. He was a MRC clinical research fellow at the University of Birmingham and National Institute for Medical Research, London. He served as a lecturer in medicine at the Welsh National School of Medicine, honorary senior registrar in medicine at United Cardiff Hospitals, and professor of medicine and director of the department of medicine at the Royal Postgraduate Medical School. He is currently the Regius Professor of Physics and Head of the Clinical School at the University of Cambridge and a Fellow of Christ's College. He was honored as Knight Bachelor in 1993 and FRS in 1995. He is a member of the Academia Europaea, Association of Physicians, Association of American Physicians, British Society for Immunology, European Society of Clinical Investigation, Scandinavian Society for Immunology, and a foreign member of the National Academy of Sciences. Sir Keith Peters is the preeminent physician-scientist in the UK. His principle scientific contributions relate to kidney disease and, in particular, the immunopathology and therapy for nephritis. He utilized the technique of plasmaphoresis and demonstrated its usefulness in the arrest of certain immunologically related diseases. His scientific contributions to medicine earned him election to the Royal Society, an unusual honor for one who is predominately a clinical scientist. This honor represents only one aspect of Sir Keith's contribution to medicine and science. He has trained many of the current leaders in UK academic medicine and has transformed the Cambridge Medical Schools, not only by the erection of new buildings but by elegant and successful recruitment to Cambridge of scientifically committed physicians. The intellectual merger of medicine in Cambridge with the existing strengths in the biological sciences has now positioned Cambridge as the leading academic medical center in Europe. That he serves on the Gairdner Foundation Award Committee and the General Motors Cancer Research Foundation reflects the high opinion that Sir Keith enjoys in this country as well. He was elected as a member of the American Philosophical Society in 1999. | |
| 4 | Name: | Dr. Thomas E. Starzl | | | Institution: | University of Pittsburgh School of Medicine | | | Year Elected: | 1999 | | | Class: | 2. Biological Sciences | | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | | Residency: | Resident | | | Living? : |
Deceased
| | | Birth Date: | 1926 | | | Death Date: | March 4, 2017 | | | | | | |
Thomas E. Starzl was director emeritus of the Thomas E. Starzl Transplantation Institute of the University of Pittsburgh and the University of Pittsburgh Medical Center at the time of his death March 4, 2017, at age 90. He received his Ph.D. in neurophysiology and his M.D. degrees at Northwestern University. Completing surgical training at The Johns Hopkins University and the University of Miami, he became a Markle Scholar and faculty member at Northwestern University. In 1962, shortly after joining the faculty at the University of Colorado, Dr. Starzl performed his first kidney transplant and subsequently the world's first human liver transplant. Within a year, he had more kidney transplant recipients surviving than all other surgeons combined. He improved immunosuppression with anti-lymphocyte globulin (ALG), cyclosporine-based treatment and tacrolimus. Largely through Dr. Starzl's efforts, transplantation of all organs came of age. Dr. Starzl joined the University of Pittsburgh faculty in 1981and performed the first of 30 liver transplants at the university that year, helping make the city the "transplant capital of the world." Retiring from clinical practice in 1991, Dr. Starzl (in collaboration with fellow APS member and Nobel laureate Rolf Zinkernagel) delineated the previously enigmatic mechanisms of organ engraftment and proposed radical modifications of immunosuppression strategy that facilitates these mechanisms. This work served to improve clinical outcomes as well as the overall understanding of the function of the immune system. In recognition of his groundbreaking work, he was awarded the Jonathan E. Rhoads Medal for Distinguished Service to Medicine in 2002 and the National Medal of Science, the nation's highest scientific honor, in 2004. He received many other honors and awards, including the 2012 Lasker Award and the Blumberg Award from the Hepatitis B Foundation (2014), as well as 24 honorary doctorates from around the world. He published almost 2,200 scientific articles and four books, including his memoir entitled The Puzzle People: Memoirs of a Transplant Surgeon. Thomas Starzl was elected to membership in the American Philosophical Society in 1999. In 2016 the Society presented him with the Benjamin Franklin Medal for Distinguished Achievement in Science. The citation read, "Tom Starzl has transformed human organ transplantation from science fiction to reliable treatment of fatal diseases, virtually changing medical practice. Fifty years ago when the world had only a handful of surviving kidney transplant recipients he showed that rejection was reversible, allowing consistent success. His introduction of new immunosuppressive agents helped him to accomplish the first liver and multivisceral transplants. His studies explain liver regeneration and determine that this organ controls lipid metabolism. His discovery of persistent donor cell chimerism in successful recipients points the way to allograft tolerance without chronic immunosuppression. In recognition of his profound contributions the American Philosophical Society salutes Thomas E. Starzl by awarding him its highest honor." | |
| |